Equity · Healthcare
UPB
NASDAQUpstream Bio (UPB)
The line runs 5.37 USD on 21 September through 1.57 USD on 20 November, on a scale from 0 to 6. Days the market did not trade hold the previous close, flat.
- Market cap
- 86.1M USD
- Revenue, year to Dec 2025
- 2.9M USD
- EPS, diluted, year to Dec 2025
- −2.66 USD
- Avg volume
- 101.3K
- Mentions, 30 days
- 1
as of Nov 20, 2026
Have Upstream Bio (UPB) insiders bought or sold shares recently?
In the 90 days to 22 Nov 2026, Upstream Bio insiders reported 5 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 2 Jan 2026, show no open-market purchase.
Form 4, 90 days to 22 Nov 2026, newest reported trade 16 Sep 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 16 Sep 2026 | Deykin AaronChief Medical Officer | Sell | 895 | 5K USD |
| 16 Sep 2026 | Sutherland Everett RandChief Executive Officer | Sell | 2,095 | 12K USD |
| 16 Sep 2026 | Houghton AdamChief Business Officer | Sell | 700 | 4K USD |
| 16 Sep 2026 | GRAY MICHAELCFO and COO | Sell | 853 | 5K USD |
| 16 Sep 2026 | Ambrose AllisonGeneral Counsel | Sell | 485 | 3K USD |
| Sold | 5 open-market sales | 5,028 | $28K |
Which funds hold Upstream Bio (UPB)?
10 of the 45 institutional funds we track reported a Upstream Bio position for the quarter ended 30 Sep 2026 — a combined 22.6M USD; the latest of those filings landed 16 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| D. E. Shaw & Co. | Added | 1,398,735 | 7.4M USD | +35.0% |
| Millennium Management | Held (±25%) | 1,168,181 | 6.2M USD | +2.1% |
| Two Sigma Investments | Added | 428,190 | 2.3M USD | +911.7% |
| AQR Capital Management | Held (±25%) | 415,734 | 2.2M USD | −23.7% |
| Point72 Asset Management | Held (±25%) | 372,823 | 2.0M USD | −17.7% |
| Renaissance Technologies | Added | 194,700 | 1.0M USD | +48.3% |
| Marshall Wace | New position | 135,771 | 716K USD | |
| Man Group | Held (±25%) | 88,782 | 468K USD | +20.3% |
| Citadel Advisors | New position | 59,042 | 311K USD | |
| Tudor Investment Corp | New position | 26,755 | 141K USD |
What has been filed or recorded for Upstream Bio (UPB)?
The filings we hold for Upstream Bio, newest first: 1 fails-to-deliver day, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 13 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 800 shares | 3K USD notional · 0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.75 USD | Revenue $0M |
| 30 Sep 2026 | Financials | Total assets | 246.0M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 234.0M USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.73 USD | Revenue $1M |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.75 USD | Revenue $1M |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −2.66 USD | Revenue $3M |
| 31 Dec 2025 | Financials | Revenue | 2.9M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −143.4M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −2.66 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.63 USD | Revenue $1M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.74 USD | Revenue $1M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.51 USD | Revenue $1M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −5.58 USD | Revenue $2M |
What is Reddit saying about Upstream Bio (UPB)?
Reddit mentioned UPB 1 times in the 30 days to 21 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 21 November 2026.
30-day window, Method
How do Reddit mentions of Upstream Bio (UPB) compare with its price?
Share ↗
Which subreddits are talking about Upstream Bio (UPB)?
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 100% | 1 | +0.12 |
What do people ask about Upstream Bio (UPB)?
What did Upstream Bio shares close at?1.57
Upstream Bio closed at 1.57 USD on 20 Nov 2026, down 21.70% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Upstream Bio’s market cap?86.1M
Upstream Bio is worth 86.1M USD by market value as of 20 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Upstream Bio’s revenue?2.9M
Upstream Bio reported revenue of 2.9M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Upstream Bio insiders bought or sold shares recently?5 sales
In the 90 days to 22 Nov 2026, Upstream Bio insiders reported 5 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 2 Jan 2026, show no open-market purchase. See Insiders
Which funds own Upstream Bio?10 of 45
10 of the 45 funds we track reported a Upstream Bio position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were D. E. Shaw & Co., Millennium Management and Two Sigma Investments. See Funds
When did Upstream Bio last report earnings?−0.75
Upstream Bio last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.75 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Upstream Bio?1 mentions
Upstream Bio was mentioned 1 times in the last 7 days across the finance subreddits we track, and 1 times over the trailing 30 days. Of the 1 mentions scored for sentiment, 100% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings
- SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words